Stock listing

AZN Stock Price, News, Filings & Events — Astrazeneca Plc

Selected listing: AZN · NYSE · USD · US

This page tracks Astrazeneca Plc's AZN:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZN:NYSE. AZN:NYSE is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. AstraZeneca Plc is a publicly traded company listed on the UK market under the ticker AZN. The company has a market capitalization of approximately £261.99 billion. AstraZeneca focuses on the research, development, and commercialization of prescription medicines across various therapeutic areas.

AZN:NYSEUSDUSUpdated August 14, 2026
Astrazeneca Plc logo
Ticker
AZN:NYSE
Asset type
Stock
Market cap
$244.88B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NYSE
Currency
USD

Astrazeneca Plc AZN:NYSE stock context

This page tracks Astrazeneca Plc's AZN:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZN:NYSE. AZN:NYSE is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. AstraZeneca Plc is a publicly traded company listed on the UK market under the ticker AZN. The company has a market capitalization of approximately £261.99 billion. AstraZeneca focuses on the research, development, and commercialization of prescription medicines across various therapeutic areas.

Research Astrazeneca Plc

Alternate listings